Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by KBC Group NV

KBC Group NV lowered its stake in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 34.8% in the third quarter, HoldingsChannel reports. The fund owned 12,053 shares of the medical instruments supplier’s stock after selling 6,420 shares during the quarter. KBC Group NV’s holdings in Mettler-Toledo International were worth $18,076,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. EverSource Wealth Advisors LLC increased its position in shares of Mettler-Toledo International by 8.0% in the first quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock worth $117,000 after acquiring an additional 7 shares in the last quarter. UMB Bank n.a. boosted its stake in Mettler-Toledo International by 6.6% during the 2nd quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock valued at $158,000 after acquiring an additional 7 shares during the last quarter. Bellevue Group AG grew its stake in Mettler-Toledo International by 32.0% in the first quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock worth $44,000 after purchasing an additional 8 shares in the last quarter. Massmutual Trust Co. FSB ADV increased its stake in Mettler-Toledo International by 7.2% during the second quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock valued at $166,000 after purchasing an additional 8 shares during the last quarter. Finally, DT Investment Partners LLC raised its stake in Mettler-Toledo International by 13.3% during the third quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock worth $102,000 after acquiring an additional 8 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,179.58 on Friday. The business’s 50-day simple moving average is $1,385.96 and its 200-day simple moving average is $1,400.67. Mettler-Toledo International Inc. has a 52 week low of $1,041.49 and a 52 week high of $1,546.93. The firm has a market cap of $24.89 billion, a price-to-earnings ratio of 31.80, a P/E/G ratio of 4.16 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. The business had revenue of $954.54 million during the quarter, compared to the consensus estimate of $941.93 million. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. As a group, equities research analysts forecast that Mettler-Toledo International Inc. will post 40.37 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Elisha W. Finney sold 76 shares of Mettler-Toledo International stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the sale, the director now directly owns 240 shares of the company’s stock, valued at $314,820. This trade represents a 24.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.94% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on MTD. JPMorgan Chase & Co. boosted their target price on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Robert W. Baird cut their price objective on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. Evercore ISI increased their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Wells Fargo & Company lowered their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Finally, Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International has an average rating of “Hold” and a consensus price target of $1,338.75.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.